Home › Diffuse Intrinsic Pontine Glioma › Texas › Houston

Pag-aaral pangklinika para sa Diffuse Intrinsic Pontine Glioma sa Houston, TX

Isang pag-aaral para sa Diffuse Intrinsic Pontine Glioma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Houston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Nagre-recruitPhase 2

Texas Children's Hospital, Houston

12 Months – 39 Years · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06838676

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

Nagre-recruitPhase 1/2

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston

12 Months – 21 Years · Lahat ng kasarian · Na-update Set 11, 2026 · NCT04870944

Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation

Nagre-recruitPhase 1

The University of Texas M. D. Anderson Cancer Center, Houston

36 Months · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07076498

Targeted Pediatric High-Grade Glioma Therapy

Nagre-recruitObservasyonal na pag-aaral

Texas Children's Hospital, Houston

12 Months – 39 Years · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

Nagre-recruitPhase 2

Texas Children's Hospital, Houston

Edad 12 hanggang 39 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06161974

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Nagre-recruitPhase 2

Texas Children's Hospital, Houston

Edad 3 hanggang 39 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05096481

C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)

Nagre-recruitPhase 1

Texas Children's Hospital, Houston

12 Months – 25 Years · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT04099797

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo

Texas Children's Hospital, Houston

Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT06333899

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Nagre-recruitPhase 2

Texas Children's Hospital, Houston

12 Months – 39 Years · Lahat ng kasarian · Na-update May 29, 2026 · NCT05843253

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

Nagre-recruitMaagang Phase 1

Texas Children's Hospital, Houston

Hanggang edad 21 · Lahat ng kasarian · Na-update Mar 18, 2026 · NCT04655404

Pag-aaral para sa Diffuse Intrinsic Pontine Glioma sa ibang lungsod

Iba pang pag-aaral sa Houston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.